Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Intuitive Surgical (ISRG)

NASDAQ: ISRG · Medical Instruments · Sunnyvale, CA

Our rating: Positive

Positive reaffirmed at $443.85, moderate conviction, October 22, 2026.

Breaks if: The Positive view would break if year-over-year revenue growth falls below 12% — roughly half the current 20.5% rate — for two consecutive quarters within the next twelve months, signaling the franchise is decelerating faster than the 56x multiple can absorb. A sustained decline in net margin below 22% for two straight quarters would likewise prompt a downgrade, indicating operating leverage is reversing rather than building. Either condition confirmed in back-to-back quarters would shift the call toward Cautious.

Key figures

Market value$138.3B
Revenue, last 12 months$11.6B
Net income, last 12 months$3.0B
Free cash flow, last 12 months$3.6B
Price to earnings46.8×
Free cash flow yield2.6%
Dividend yield0.0%
Operating margin28.4%
Return on equity18.0%
Beta to the S&P 5001.08
Volatility, annualized34.4%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$3.0B21.7%$1.49$1.1B
June 30, 2026$2.9B18.5%$2.29$948M
March 31, 2026$2.8B23.0%$2.28$809M
December 31, 2025$2.9B18.8%$2.20$730M
September 30, 2025$2.5B22.9%$1.95$736M
June 30, 2025$2.4B21.4%$1.81$560M
March 31, 2025$2.3B19.2%$1.92$465M
December 31, 2024$2.4B25.2%$1.89$511M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

21 ledger entries and 19 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.